Product Information
FLUVOXAMINE ER 150 MG CAPSULE is a generic product labeled by Bionpharma Inc., priced at $4.9611 per EA under NDC 69452018313. Its NADAC has been published 98 times since Aug 14, 2024.
Strength
150 mg/1
Manufacturer
Bionpharma Inc.NDC
69452018313
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
FLUVOXAMINE MALEATEApproval Type
Generic (ANDA)
FDA Application
ANDA212182On Market Since
7/1/2020
Pharmacological Classes
Price Statistics
The NADAC for FLUVOXAMINE ER 150 MG CAPSULE has been published 98 times since Aug 14, 2024, and over the history we have for it it has risen 35.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.9611 per EA |
|---|---|
| All-time high | $5.6905 (Oct 16, 2024) |
| All-time low | $3.6682 (Aug 14, 2024) |
| 52-week high | $5.6209 |
| 52-week low | $4.7857 |
| Median price | $5.2792 |
| Average price | $5.1696 |
| Largest weekly change | +25.6% (Sep 18, 2024) |
| Weeks tracked | 98 |
| Tracking since | Aug 14, 2024 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of FLUVOXAMINE ER 150 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for FLUVOXAMINE ER 150 MG CAPSULE, manufactured by Bionpharma Inc., is $4.9611 per EA (NDC 69452018313), effective Jun 24, 2026.
How has the price of FLUVOXAMINE ER 150 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for FLUVOXAMINE ER 150 MG CAPSULE has risen 35.2%. It has been tracked across 98 weekly CMS publications since Aug 14, 2024.
What are the highest and lowest recorded NADAC prices for FLUVOXAMINE ER 150 MG CAPSULE?
Since Aug 14, 2024, the NADAC for FLUVOXAMINE ER 150 MG CAPSULE has ranged from a low of $3.6682 (Aug 14, 2024) to a high of $5.6905 (Oct 16, 2024), with a median of $5.2792 per EA.
Are there cheaper alternatives to FLUVOXAMINE ER 150 MG CAPSULE?
3 NADAC-published products share the same active ingredient, strength, and dosage form as FLUVOXAMINE ER 150 MG CAPSULE, but none are currently priced below it.
Who manufactures FLUVOXAMINE ER 150 MG CAPSULE?
FLUVOXAMINE ER 150 MG CAPSULE (NDC 69452018313) is labeled by Bionpharma Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification